Doxorubicin action on mitochondria: relevance to osteosarcoma therapy?
The mitochondria may very well determine the final commitment of the cell to death, particularly in times of energy stress. Cancer chemotherapeutics such as the anthracycline doxorubicin perturb mitochondrial structure and function in tumour cells, as evidenced in osteosarcoma, for which doxorubicin...
| Main Authors: | Armstrong, J., Dass, Crispin |
|---|---|
| Format: | Journal Article |
| Published: |
2015
|
| Online Access: | http://hdl.handle.net/20.500.11937/16891 |
Similar Items
Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model
by: Tan, M., et al.
Published: (2013)
by: Tan, M., et al.
Published: (2013)
Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment: Comparison with osteosarcoma cells
by: Tacar, O., et al.
Published: (2015)
by: Tacar, O., et al.
Published: (2015)
Making gene therapy for osteosarcoma a reality
by: Broadhead, M., et al.
Published: (2010)
by: Broadhead, M., et al.
Published: (2010)
Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis
by: Friedhuber, A., et al.
Published: (2015)
by: Friedhuber, A., et al.
Published: (2015)
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
by: Tacar, O., et al.
Published: (2013)
by: Tacar, O., et al.
Published: (2013)
Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model
by: Broadhead, M., et al.
Published: (2011)
by: Broadhead, M., et al.
Published: (2011)
Doxorubicin: The dogma and the bone
by: Wong, J., et al.
Published: (2016)
by: Wong, J., et al.
Published: (2016)
In vitro delivery and controlled release of doxorubicin for targeting osteosarcoma bone cancer
by: Kamba, Shafiu Abdullahi, et al.
Published: (2013)
by: Kamba, Shafiu Abdullahi, et al.
Published: (2013)
Canine osteosarcoma: a relevant comparative model for osteosarcoma in man
by: Selvarajah, Gayathri Thevi
Published: (2011)
by: Selvarajah, Gayathri Thevi
Published: (2011)
The Molecular Pathogenesis of Osteosarcoma: A Review
by: Choong, P., et al.
Published: (2011)
by: Choong, P., et al.
Published: (2011)
Cell and Molecular Biology Underpinning the Effects of PEDF on Cancers in General and Osteosarcoma in Particular
by: Chandolu, V., et al.
Published: (2012)
by: Chandolu, V., et al.
Published: (2012)
Anti-Tumour Effect of a Chitosan Delivery System for Doxorubicin
by: Tan, M., et al.
Published: (2010)
by: Tan, M., et al.
Published: (2010)
Doxorubicin, mesenchymal stem cell toxicity and antitumour activity: implications for clinical use
by: Baxter-Holland, M., et al.
Published: (2018)
by: Baxter-Holland, M., et al.
Published: (2018)
Stability of freeze-dried pH-responsive dextrin nanogels containing doxorubicin
by: Manchun, S., et al.
Published: (2016)
by: Manchun, S., et al.
Published: (2016)
Doxorubicin-induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes?
by: Tacar, O., et al.
Published: (2013)
by: Tacar, O., et al.
Published: (2013)
Efficacy of Continuously Administered PEDF-Derived Synthetic Peptides against Osteosarcoma Growth and Metastasis
by: Broadhead, M., et al.
Published: (2012)
by: Broadhead, M., et al.
Published: (2012)
Thiolated pectin–doxorubicin conjugates: Synthesis, characterization and anticancer activity studies
by: Cheewatanakornkool, K., et al.
Published: (2017)
by: Cheewatanakornkool, K., et al.
Published: (2017)
Curcumin Analog DK1 Induces Apoptosis in Human Osteosarcoma Cells In Vitro through Mitochondria-Dependent Signaling Pathway
by: Muhammad Nazirul Mubin, Aziz, et al.
Published: (2018)
by: Muhammad Nazirul Mubin, Aziz, et al.
Published: (2018)
Curcumin analog DK1 induces apoptosis in human osteosarcoma cells in vitro through mitochondria-dependent signaling pathway
by: Aziz, Muhammad Nazirul Mubin, et al.
Published: (2018)
by: Aziz, Muhammad Nazirul Mubin, et al.
Published: (2018)
Mitochondria dysfunction and bipolar disorder: from pathology to therapy
by: Lam, Xin-Jieh, et al.
Published: (2023)
by: Lam, Xin-Jieh, et al.
Published: (2023)
RANK-Fc inhibits malignancy via inhibiting ERK activation and evoking caspase-3-mediated anoikis in human osteosarcoma cells
by: Akiyama, T., et al.
Published: (2010)
by: Akiyama, T., et al.
Published: (2010)
The Effect of Krill Oil and n-3 Polyunsaturated Fatty Acids on Human Osteosarcoma Cell Proliferation and Migration.
by: Xiao, S., et al.
Published: (2015)
by: Xiao, S., et al.
Published: (2015)
Enhanced anti-tumor effect of pH-responsive dextrin nanogels delivering doxorubicin on colorectal cancer
by: Manchun, S., et al.
Published: (2015)
by: Manchun, S., et al.
Published: (2015)
Zoledronic acid: Pleiotropic anti-tumor mechanism and therapeutic outlook for osteosarcoma
by: Ouyang, Z., et al.
Published: (2018)
by: Ouyang, Z., et al.
Published: (2018)
Redox-responsive microbeads containing thiolated pectin-doxorubicin conjugate inhibit tumor growth and metastasis: An in vitro and in vivo study
by: Cheewatanakornkool, K., et al.
Published: (2018)
by: Cheewatanakornkool, K., et al.
Published: (2018)
Novel pH-responsive dextrin nanogels for doxorubicin delivery to cancer cells with reduced cytotoxicity to cardiomyocytes and stem cells
by: Manchun, S., et al.
Published: (2014)
by: Manchun, S., et al.
Published: (2014)
Characterization and in vitro release studies of oral microbeads containing thiolated pectin-doxorubicin conjugates for colorectal cancer treatment
by: Cheewatanakornkool, K., et al.
Published: (2017)
by: Cheewatanakornkool, K., et al.
Published: (2017)
RECK in Osteosarcoma: A Novel Role in Tumour Vasculature and Inhibition of Tumorigenesis in an Orthotopic Mode
by: Clark, J., et al.
Published: (2011)
by: Clark, J., et al.
Published: (2011)
The role of mitochondria in ageing
by: Pollard, Amelia K.
Published: (2017)
by: Pollard, Amelia K.
Published: (2017)
Mitochondria: Redox metabolism and dysfunction
by: Kang, J., et al.
Published: (2012)
by: Kang, J., et al.
Published: (2012)
New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis
by: Clark, J., et al.
Published: (2010)
by: Clark, J., et al.
Published: (2010)
The Islamic ethics of mitochondria transplantation
by: Bouzanita, Anke Iman, et al.
Published: (2017)
by: Bouzanita, Anke Iman, et al.
Published: (2017)
The Islamic ethics of mitochondria transplantation
by: Bouzenita, Anke Iman, et al.
Published: (2016)
by: Bouzenita, Anke Iman, et al.
Published: (2016)
Doxorubicin-loaded magnetic gold nanoshells for a combination therapy of hyperthermia and drug delivery
by: Mohammad, Faruq, et al.
Published: (2014)
by: Mohammad, Faruq, et al.
Published: (2014)
Nanoscale strategies: doxorubicin resistance challenges and enhancing cancer therapy with advanced nanotechnological approaches
by: Lim, Jian Xin, et al.
Published: (2025)
by: Lim, Jian Xin, et al.
Published: (2025)
Pigment epithelium-derived factor upregulates collagen I and downregulates matrix metalloproteinase 2 in osteosarcoma cells, and colocalises to collagen I and heat shock protein 47 in fetal and adult bone
by: Alcantara, M., et al.
Published: (2014)
by: Alcantara, M., et al.
Published: (2014)
Biodegradable drug delivery systems for cancer therapy
by: Wong, T., et al.
Published: (2017)
by: Wong, T., et al.
Published: (2017)
Heat shock protein expression analysis in canine osteosarcoma reveals HSP60 as a potentially relevant therapeutic target
by: Selvarajah, Gayathri Thevi, et al.
Published: (2013)
by: Selvarajah, Gayathri Thevi, et al.
Published: (2013)
Mitochondria and diabetes: An intriguing pathogenetic role
by: Newsholme, Philip, et al.
Published: (2012)
by: Newsholme, Philip, et al.
Published: (2012)
Metabolic adaptation to chronic hypoxia in cardiac mitochondria
by: Heather, Lisa C., et al.
Published: (2012)
by: Heather, Lisa C., et al.
Published: (2012)
Similar Items
-
Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model
by: Tan, M., et al.
Published: (2013) -
Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment: Comparison with osteosarcoma cells
by: Tacar, O., et al.
Published: (2015) -
Making gene therapy for osteosarcoma a reality
by: Broadhead, M., et al.
Published: (2010) -
Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis
by: Friedhuber, A., et al.
Published: (2015) -
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
by: Tacar, O., et al.
Published: (2013)